Institutional investors hold a majority ownership of MYGN through the 122.91% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2015, these large investors purchased a net $3.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BUCKINGHAM CAPITAL MANAGEMENT, I... Bought 41.5 Thousand shares of Myriad Genetics Inc
CREDIT SUISSE AG Bought 20.2 Thousand shares of Myriad Genetics Inc
FOX RUN MANAGEMENT LLC Bought 19.5 Thousand shares of Myriad Genetics Inc